The Pathogenesis of Insulin-Dependent Diabetes Mellitus

New England Journal of Medicine

Volumn 331, Issue 21, 1994, Pages 1428-1436

  Epstein, Franklin H ^a   Atkinson, Mark A ^b   Maclaren, Noel K ^b  

^a University of Florida College of Medicine ^*

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN;

AUTOIMMUNE DISEASE; CELLULAR IMMUNITY; HUMAN; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET; REVIEW; GENETICS; PANCREAS ISLET CELL; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR;

AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; DIABETES MELLITUS, INSULIN-DEPENDENT; HUMAN; IMMUNITY, CELLULAR; ISLETS OF LANGERHANS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028779842     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199411243312107     Document Type: Review

References (99)

1. Diabetes Epidemiology Research International Mortality Study Group. Major cross-country differences in risk of dying for people with IDDM. Diabetes Care 1991; 14:49-54
2. Green A, Gale EAM, Patterson CC Incidence of childhood-onset insulin-dependent diabetes mellitus: the EURODIAB ACE study. Lancet 1992; 339:905-909
3. Maclaren N, Atkinson M Is insulin-dependent diabetes mellitus environmentally induced? N Engl J Med 1992; 327:348-349
4. Kostraba JN What can epidemiology tell us about the role of infant diet in the etiology of IDDM? Diabetes Care 1994; 17:87-91
5. Tuomilehto J, Rewers M, Reunanen A, Increasing trend in type 1 (insulin dependent) diabetes mellitus in childhood in Finland. Diabetologia 1991; 34:282-287
6. Drykoningen CE, Mulder AL, Vaandrager GJ, LaPorte RE, Bruining GJ The incidence of male childhood type 1 (insulin-dependent) diabetes mellitus is rising rapidly in the Netherlands. Diabetologia 1992; 35:139-142
7. Barnett AH, Eff C, Leslie RDG, Pyke DA Diabetes in identical twins: a study of 200 pairs. Diabetologia 1981; 20:87-93
8. LaPorte RE, Cruickshanks KJ. Incidence and risk factors for insulin-dependent diabetes. In: National Diabetes Data Group. Diabetes in America: diabetes data compiled 1984. Bethesda, Md.: Department of Health and Human Services, 1985:III-1-III-12. (NIH publication no. 85-1468.)
9. Amiel SA, Caprio S, Sherwin RS, Plewe G, Haymond MW, Tamborlane WV Insulin resistance of puberty: a defect restricted to peripheral glucose metabolism. J Clin Endocrinol Metab 1991; 72:277-282
10. Krolewski AS, Warram JH, Rand LI, Kahn CR Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. N Engl J Med 1987; 317:1390-1398
11. Dalton TA, Bennett JC Autoimmune disease and the major histocompatibility complex: therapeutic implications. Am J Med 1992; 92:183-188
12. Todd JA, Bain SC A practical approach to identification of susceptibility genes for IDDM. Diabetes 1992; 41:1029-1034
13. Maclaren N, Riley W, Skordis N, Inherited susceptibility to insulin-dependent diabetes is associated with HLA-DR1, while DR5 is protective. Autoimmunity 1988; 1:197-205
14. Todd JA Genetic control of autoimmunity in type 1 diabetes. Immunol Today 1990; 11:122-129
15. Nepom GT A unified hypothesis for the complex genetics of HLA associations with IDDM. Diabetes 1990; 39:1153-1157
16. Sheehy MJ HLA and insulin-dependent diabetes: a protective perspective. Diabetes 1992; 41:123-129
17. Raffel LJ, Vadheim CM, Klein R, HLA-DR and the 5' insulin gene polymorphism in insulin dependent diabetes. Metabolism 1991; 40:1244-1248
18. Lucassen AM, Julier C, Beressi J-P, Susceptibility to insulin dependent diabetes mellitus maps to a 4.1 kb segment of DNA spanning the insulin gene and associated VNTR. Nat Genet 1993; 4:305-310
19. Caillat-Zucman S, Bertin E, Timsit J, Boitard C, Assan R, Bach J-F Protection from insulin-dependent diabetes mellitus is linked to a peptide transporter gene. Eur J Immunol 1993; 23:1784-1788
20. Faustman D, Li XP, Lin HY, Linkage of faulty major histocompatibility complex class I to autoimmune diabetes. Science 1991; 254:1756-1761
21. Davies JL, Kawaguchi Y, Bennett ST, A genome-wide search for human type 1 diabetes susceptibility genes. Nature 1994; 371:130-136
22. Warram JH, Krolewski AS, Gottlieb MS, Kahn CR Differences in risk of insulin-dependent diabetes in offspring of diabetic mothers and diabetic fathers. N Engl J Med 1984; 311:149-152
23. Vadheim CM, Rotter JI, Maclaren NK, Riley WJ, Anderson CE Preferential transmission of diabetic alleles within the HLA gene complex. N Engl J Med 1986; 315:1314-1318
24. Gepts W Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 1965; 14:619-633
25. Pickup G, Williams G, eds. Textbook of diabetes. Oxford, England: Blackwell Scientific, 1991.
26. Foulis AK, Liddle CN, Farquharson MA, Richmond JA, Weir RS The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia 1986; 29:267-274
27. Bottazzo GF, Dean BM, McNally JM, MacKay EH, Swift PGF, Gamble DR In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 1985; 313:353-360
28. Foulis AK, Farquharson MA, Meager A Immunoreactive alpha-interferon in insulin-secreting beta cells in type 1 diabetes mellitus. Lancet 1987; 2:1423-1427
29. Foulis AK, McGill M, Farquharson MA Insulitis in type 1 (insulin-dependent) diabetes mellitus in man macrophages, lymphocytes, and interferon-gamma containing cells. J Pathol 1991; 165:97-103
30. Hanninen A, Jalkanen S, Salmi M, Toikkanen S, Nikolakaros G, Simell O Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus. J Clin Invest 1992; 90:1901-1910
31. Gepts W, LeCompte PM. The pathology of type I (juvenile) diabetes. In: Volk BW, Arquilla ER, eds. The diabetic pancreas. 2nd ed. New York: Plenum Medical, 1985:337-65.
32. Bottazzo GF, Florin-Christensen A, Doniach D Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974; 2:1279-1283
33. Palmer JP, Asplin CM, Clemons P, Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 1983; 222:1337-1339
34. Bruining GJ, Molenaar JL, Grobbee DE, Ten-year follow-up study of islet-cell antibodies and childhood diabetes mellitus. Lancet 1989; 1:1100-1103
35. Bonifacio E, Bingley PJ, Shattock M, Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 1990; 335:147-149
36. Riley WJ, Maclaren NK, Krischer J, A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med 1990; 323:1167-1172
37. Krischer JP, Schatz D, Riley WJ, Insulin and islet cell autoantibodies as time-dependent covariates in the development of insulin-dependent diabetes: a prospective study in relatives. J Clin Endocrinol Metab 1993; 77:743-749
38. Ziegler AG, Baumgartl HJ, Standl E, Mehnert H Risk of progression to diabetes of low titer ICA-positive first-degree relatives of type I diabetics in southern Germany. J Autoimmun 1990; 3:619-624
39. Deschamps I, Boitard C, Hors J, Life table analysis of the risk of type 1 (insulin-dependent) diabetes mellitus in siblings according to islet cell antibodies and HLA markers: an 8-year prospective study. Diabetologia 1992; 35:951-957
40. Atkinson MA, Maclaren NK, Riley WJ, Winter WE, Fisk DD, Spillar RP Are insulin autoantibodies markers for insulin-dependent diabetes mellitus? Diabetes 1986; 35:894-898
41. Vardi P, Dib SA, Tuttleman M, Competitive insulin autoantibody assay: prospective evaluation of subjects at high risk for development of type I diabetes mellitus. Diabetes 1987; 36:1286-1291
42. Ziegler R, Alper CA, Awdeh ZL, Specific association of HLA-DR4 with increased prevalence and level of insulin autoantibodies in first-degree relatives of patients with type I diabetes. Diabetes 1991; 40:709-714
43. Eisenbarth GS, Jackson RA, Pugliese A Insulin autoimmunity: the rate limiting factor in pre-type I diabetes. J Autoimmun 1992; 5: Suppl A: 241-246
44. Vardi P, Ziegler AG, Mathews JH, Concentration of insulin autoantibodies at onset of type I diabetes: inverse log-linear correlation with age. Diabetes Care 1988; 11:736-739
45. Vardi P, Crisa L, Jackson RA Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of type 1 (insulin-dependent) diabetic patients. Diabetologia 1991; 34:93-102
46. Palmer JP, McCulloch DK Prediction and prevention of IDDM 1991. Diabetes 1991; 40:943-947
47. Ganda OP, Srikanta S, Brink SJ, Differential sensitivity to beta-cell secretagogues in “early”, type I diabetes mellitus. Diabetes 1984; 33:516-521
48. Nayak RC, Omar MA, Rabizadeh A, Srikanta S, Eisenbarth GS “Cytoplasmic” islet cell antibodies: evidence that the target antigen is a sialoglycoconjugate. Diabetes 1985; 34:617-619
49. Baekkeskov S, Nielsen JH, Marner B, Bilde T, Ludvigsson J, Lernmark A Autoantibodies in newly diagnosed diabetic children with immunoprecipitate human pancreatic islet cell proteins. Nature 1982; 298:167-169
50. Atkinson MA, Maclaren NK, Scharp DW, Lacy PE, Riley WJ 64,000 Mr4 autoantibodies are predictive of insulin-dependent diabetes. Lancet 1990; 335:1357-1360
51. Solimena M, Folli F, Aparisi R, Pozza G, De Camilli P Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N Engl J Med 1990; 322:1555-1560
52. Baekkeskov S, Aanstoot HJ, Christgau S, Identification of the 64K autoantigen in insulin-dependent diabetes is the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990; 347:151-156 [Erratum, Nature 1990;347:782.]
53. Genovese S, Bonifacio E, McNally JM, Distinct cytoplasmic islet cell antibodies with different risks for type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1992; 35:385-388
54. Gianani R, Pugliese A, Bonner-Weir S, Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type I diabetes. Diabetes 1992; 41:347-353
55. Atkinson MA, Kaufman DL, Newman D, Tobin AJ, Maclaren NK Islet cell cytoplasmic autoantibody reactivity to glutamate decarboxylase in insulin-dependent diabetes. J Clin Invest 1993; 91:350-356
56. Kaufman DL, Erlander MG, Clare-Salzler M, Atkinson MA, Maclaren NK, Tobin AJ Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest 1992; 89:283-292
57. Christie MR, Hollands JA, Brown TJ, Michelsen BK, Delovitch TL Detection of pancreatic islet 64,000 Mr autoantigens in insulin-dependent diabetes distinct from glutamate decarboxylase. J Clin Invest 1993; 92:240-248
58. Christie MR, Tun RY, Lo SS, Antibodies to GAD and tryptic fragments of islet 64K antigen as distinct markers for development of IDDM: studies with identical twins. Diabetes 1992; 41:782-787
59. Karjalainen J, Martin JM, Knip M, A bovine albumin peptide as a possible trigger of insulin-dependent diabetes mellitus. N Engl J Med 1992; 327:302-307 [Erratum, N Engl J Med 1992;327:1252.]
60. Pietropaolo M, Castano L, Babu S, Islet cell autoantigen 69 kD (ICA69): molecular cloning and characterization of a novel diabetes-associated autoantigen. J Clin Invest 1993; 92:359-371
61. Atkinson MA, Bowman MA, Kao K-J, Lack of immune responsiveness to bovine serum albumin in insulin-dependent diabetes. N Engl J Med 1993; 329:1853-1858
62. Castano L, Russo E, Zhou L, Lipes MA, Eisenbarth GS Identification and cloning of a granule autoantigen (carboxypeptidase-H) associated with type I diabetes. J Clin Endocrinol Metab 1991; 73:1197-1201
63. Johnson JH, Crider BP, McCorkle K, Alford M, Unger RH Inhibition of glucose transport into rat islet cells by immunoglobulins from patients with new-onset insulin-dependent diabetes mellitus. N Engl J Med 1990; 322:653-659 [Erratum, N Engl J Med 1990;322:1019.]
64. Inman LR, McAllister CT, Chen L, Autoantibodies to the GLUT-2 glucose transporter of beta cells in insulin-dependent diabetes mellitus of recent onset. Proc Natl Acad Sci U S A 1993; 90:1281-1284
65. Buschard K, Josefsen K, Horn T, Fredman P Sulphatide and sulphatide antibodies in insulin-dependent diabetes mellitus. Lancet 1993; 342:840-840
66. Karounos DG, Wolinsky JS, Thomas JW Monoclonal antibody to rubella virus capsid protein recognizes a beta-cell antigen. J Immunol 1993; 150:3080-3085
67. Harrison LC, Chu SX, DeAizpurua HJ, Graham M, Honeyman MC, Colman PG Islet-reactive T cells are a marker of preclinical insulin-dependent diabetes. J Clin Invest 1992; 89:1161-1165
68. Roep BO, Kallan AA, Hazenbos WLW, T-cell reactivity to 38 kD insulin-secretory-granule protein in patients with recent-onset type 1 diabetes. Lancet 1991; 337:1439-1441
69. Keller RJ Cellular immunity to human insulin in individuals at high risk for the development of type I diabetes mellitus. J Autoimmun 1990; 3:321-327
70. Atkinson MA, Kaufman DL, Campbell L, Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet 1992; 339:458-459
71. Harrison LC, Honeyman MC, DeAizpurua HJ, Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet 1993; 341:1365-1369
72. Kaufman DL, Clare-Salzler M, Tian J, Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 1993; 366:69-72
73. Tisch R, Yang X-D, Singer SM, Liblau RS, Fugger L, McDevitt HO Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 1993; 366:72-75
74. Stiller CR, Dupre J, Gent M, Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset. Science 1984; 223:1362-1367
75. Wang Y, Hao L, Gill RG, Lafferty KJ Autoimmune diabetes in NOD mouse is L3T4 T-lymphocyte dependent. Diabetes 1987; 36:535-538
76. Shizuru JA, Taylor-Edwards C, Banks BA, Gregory AK, Fathman CG Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes. Science 1988; 240:659-662
77. Mandrup-Poulsen T, Bendtzen K, Nerup J, Dinarello CA, Svenson M, Nielsen JH Affinity-purified human interleukin I is cytotoxic to isolated islets of Langerhans. Diabetologia 1986; 29:63-67
78. Campbell IL, Kay TWH, Oxbrow L, Harrison LC Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J Clin Invest 1991; 87:739-742
79. Stewart TA, Hultgren B, Huang X, Pitts-Meek S, Hully J, MacLachlan NJ Induction of type I diabetes by interferon-alpha in transgenic mice. Science 1993; 260:1942-1946
80. Nomikos IN, Wang Y, Lafferty KJ Involvement of O2 radicals in autoimmune' diabetes. Immunol Cell Biol 1989; 67:85-87
81. Asayama K, Kooy NW, Burr IM Effect of vitamin E deficiency and selenium deficiency on insulin secretory reserve and free radical scavenging systems in islets: decrease of islet manganosuperoxide dismutase. J Lab Clin Med 1986; 107:459-464
82. Corbett JA, Sweetland MA, Wang JL, Lancaster JR Jr, McDaniel ML Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc Natl Acad Sci U S A 1993; 90:1731-1735
83. Bougneres PF, Carel JC, Castano L, Factors associated with early remission of type I diabetes in children treated with cyclosporine. N Engl J Med 1988; 318:663-670
84. Silverstein J, Maclaren N, Riley W, Spillar R, Radjenovic D, Johnson S Immunosuppression with azathioprine and prednisone in recent-onset insulin-dependent diabetes mellitus. N Engl J Med 1988; 319:599-604
85. Bougneres P-F, Landais P, Boisson C, Limited duration of remission of insulin dependency in children with recent overt type I diabetes treated with low-dose cyclosporin. Diabetes 1990; 39:1264-1272
86. Fathman CG, Myers BD Cyclosporine therapy for autoimmune disease. N Engl J Med 1992; 326:1693-1695
87. Shah SC, Malone JI, Simpson NE A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus. N Engl J Med 1989; 320:550-554
88. Buschard K The functional state of the beta cells in the pathogenesis of insulin-dependent diabetes mellitus. Autoimmunity 1991; 10:65-69
89. Gotfredsen CF, Buschard K, Frandsen EK Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes-prone animals. Diabetologia 1985; 28:933-935
90. Atkinson MA, Maclaren NK, Luchetta R Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes 1990; 39:933-937
91. Keller RJ, Eisenbarth GS, Jackson RA Insulin prophylaxis in individuals at high risk of type I diabetes. Lancet 1993; 341:927-928
92. Reddy S, Bibby NJ, Elliott RB Early nicotinamide treatment in the NOD mouse: effects on diabetes and insulitis suppression and autoantibody levels. Diabetes Res 1990; 15:95-102
93. Masiello P, Cubeddu TL, Frosina G, Bergamini E Protective effect of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase, against streptozotocin-induced diabetes. Diabetologia 1985; 28:683-686
94. Chase HP, Butler-Simon N, Garg S, McDuffie M, Hoops SL, O'Brien D A trial of nicotinamide in newly diagnosed patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1990; 33:444-446
95. Elliott RB, Chase HP Prevention or delay of type 1 (insulin-dependent) diabetes mellitus in children using nicotinamide. Diabetologia 1991; 34:362-365
96. Bingley PJ, Bonifacio E, Gale EAM Can we really predict IDDM? Diabetes 1993; 42:213-220
97. Zhang ZJ, Davidson L, Eisenbarth G, Weiner HL Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci U S A 1991; 88:10252-10256
98. Weiner HL, Mackin GA, Matsui M, Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 1993; 259:1321-1324
99. Shehadeh N, Calcinaro F, Bradley BJ, Bruchlim I, Vardi P, Lafferty KJ Effect of adjuvant therapy on development of diabetes in mouse and man. Lancet 1994; 343:706-707